A humanized anti-CD19 antibody variant VH16 R94K/S324N-VL43 V3Q/T7S/P44I/N92A derived from murine antibody FMC63. Injection of anti-CD19 antibody huFMC63-1 resulted in a B cell depletion in the spleens of treated mice.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.